tradingkey.logo

Viking Therapeutics' oral weight-loss pill meets expectations in mid-stage study

ReutersAug 19, 2025 11:15 AM

- Viking Therapeutics VKTX.O said on Tuesday its experimental weight-loss pill helped patients with obesity lose nearly 12.2% of their body weight on average over 13 weeks in a mid-stage study.

Analysts ahead of the results had expected weight loss in the range of 10% to 15% on average and greater than the 8.2% seen in a small early-stage trial.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI